Baird Financial Group
TWST icon

Baird Financial Group’s Twist Bioscience TWST Stock Holding History

Baird Financial Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.13M Sell
49,862
-4,005
-7% -$261K 0.01% 777
2026
Q1 		$2.56M Buy
+53,867
New +$2.42M ﹤0.01% 968
2021
Q2 		– Sell
-4,059
Closed -$503K – 1782
2021
Q1 		$503K Buy
+4,059
New +$616K ﹤0.01% 1354
2020
Q3 		– Sell
-11,881
Closed -$538K – 1574
2020
Q2 		$538K Buy
+11,881
New +$426K ﹤0.01% 1126

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Baird Financial Group's TWST Position: Q2 2026 in Review

Baird Financial Group reduced its Twist Bioscience (TWST) stake by 7.4% in Q2 2026, selling an estimated $261K and leaving 49,862 shares worth $5.13M. The position accounts for 0.01% of the portfolio, ranked #777.

Baird Financial Group first reported a position in TWST in Q2 2020 and has held it in 4 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Baird Financial Group held 49,862 shares of Twist Bioscience worth $5.13M as of Q2 2026.
  • Baird Financial Group sold 4,005 Twist Bioscience shares in Q2 2026, an estimated $261K.
  • Twist Bioscience made up 0.01% of Baird Financial Group's portfolio in Q2 2026, its #777 holding.
  • Baird Financial Group first reported a position in Twist Bioscience in Q2 2020 and has held it in 4 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.